Spending on prescription drugs rose by 12.6% in 2014 and is projected to rise by an average 7.3% annually through 2018, according to a new report by the Department of Health and Human Services. The total number of prescriptions rose about 11% between 2010 and 2014, while expenditures rose 26% during the period. “The fact that total expenditures rose more quickly than the number of prescriptions suggests that prices are growing faster than quantities,” the report states. “Therefore price changes are contributing more to the growth in spending than is growth in volume of prescriptions.” Spending on specialty drugs, as defined by the CVS/Caremark formulary, rose by an average 11.2% annually between 2010 and 2014, accounting for about 12% of the growth in retail drug spending over the period.

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare &…
Headline
President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which…
Headline
The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less…
Headline
The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill…
Headline
Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs…